InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System

Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth ...
Stocktwits on MSN

NSPR rallies after hours on FDA green light for key stroke-prevention trial despite withdrawn annual guidance

Vascular surgeons Dr. Patrick Geraghty and Dr. Patrick Muck — who led the earlier study — will head the new trial. ・Separately, the company also announced that it has initiated a voluntary recall in ...
MassDevice

InspireMD recalls CGuard Prime 135 cm stent delivery system in US, gets nod to study neuroprotection tech

InspireMD (Nasdaq:NSPR) announced today that, in consultation with the FDA, it recalled its CGuard Prime 135 cm carotid stent ...

InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System

InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the U.S. Food and Drug ...
Healio

Q&A: TCAR, which transformed carotid artery revascularization, reaches 100,000 procedures

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There have now been more than 100,000 transcarotid ...
Nasdaq

InspireMD and NAMSA Collaborate on CGUARDIANS II Study for CGuard™ Prime Carotid Stent System

InspireMD, Inc. has partnered with NAMSA to conduct the CGUARDIANS II pivotal study, evaluating the safety and effectiveness of the CGuard Prime carotid stent system in Transcarotid Artery ...
TCTMD

Surmounting Minor Stroke: New Devices, TCAR Aim to Cut Risk of Carotid Artery Stenting

HOLLYWOOD, FL—Carotid artery stenting (CAS) and endarterectomy (CEA) remain neck and neck in vying for prominence, but some experts say a minimally invasive surgical approach known as transcarotid ...
Nasdaq

Study Published in JAMA Finds Hospital Availability of TCAR Associated with an Improvement in Overall Outcomes for Carotid Revascularization

SUNNYVALE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced positive ...
Star-News

5 things to know about TCAR procedure

The Centers for Disease Control and Prevention reports that nearly 800,000 people in the United States have suffered strokes. Stroke Awareness Month, which occurs in May, is quickly approaching, which ...
TCTMD

How to Decide TF Stent vs TCAR vs CEA

Update on ICAD... Do We Still Stent and What is Standard Medical Therapy? Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Business Wire

Vascular Quality Initiative (SVS VQI) Announces the Expansion of Medicare Coverage to Standard Surgical Risk Patients within their TCAR Surveillance Project

CHICAGO--(BUSINESS WIRE)--The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and ...